United States· US:72988-0039_213093ce-6854-cfd3-e063-6394a90a93fc
MADECASSOL
A medicinal product containing centella asiatica, registered in United States by Lydia Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CENTELLA ASIATICA
- Manufacturer
- Lydia Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11729880039110 g in 1 TUBE (72988-0039-1)
- ndc1172988-0039-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Centella asiatica in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed749af1-95de-49fb-8668-758a2eb89dc3 GET /v1/drugs/ed749af1-95de-49fb-8668-758a2eb89dc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10",
"substance": "CENTELLA ASIATICA",
"productndc": "72988-0039",
"dosage_form": "GEL",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about centella asiatica.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.